PCR239 Quality of Life (QOL) Instruments Used in Clinicaltrials.gov-Indexed Trials of Gene-Modified Cell Therapy (GMCT) in Patients With Multiple Myeloma (MM)
Abstract
Authors
S. Cadarette M. Arregui Rementeria E. Gomez Espinosa F. Stewart T. Brisibe D. Devani K. Kistler T. Oladapo N.D. Rangi E. Wissinger